RxNorm 731227 NDC Crossover
Aranesp 40 MCG in 0.4 ML Prefilled Syringe
Related NDC Codes to RxNorm Concept 731227
The following NDC codes crossover to the RxNorm Concept 731227. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
---|---|---|---|---|---|---|---|
55513-002 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-003 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-004 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-005 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-006 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-021 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-023 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-025 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-027 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-028 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-032 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-057 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-098 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-110 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-111 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE |